American Public Education (Nasdaq: APEI) surged 21% on March 13, 2026 after reporting Q4 and full-year 2025 results that crushed expectations by 80%. The stock broke past its 52-week high like it wasn’t there. The question now: Is this still a buy at $57, or did the best trade already happen?
Here’s what actually moved the stock, and what you need to watch next.
What the Q4 Numbers Actually Said
The headline numbers weren’t flashy — Q4 consolidated revenue came in at $158.3M, down 3.5% year-over-year. But that decline has a specific explanation: the federal government shutdown hit APUS enrollment directly. APUS’s core customer base is military personnel, veterans, and federal government employees. A shutdown means tuition assistance programs freeze. This wasn’t a trend break — it was a timing issue.
On the earnings line, analysts were expecting roughly $0.37 in diluted EPS for Q4. APEI delivered $0.67. That’s an 80% beat — not a rounding error, not a favorable comparison. The company found $0.30 per share that the street didn’t model. Margins came through: Q4 gross margin was 56.5%, operating margin hit 12%.
Full-year 2025 picture:
- Revenue: $648.9M (+3.9%)
- Adjusted EBITDA: $85.7M (+18.6%)
- Diluted EPS: $1.36 vs. $0.55 in 2024 (+147%)
- Free cash flow: $46.1M (up from $7.8M in 2024 — a 490% jump)
- Net income to common: $25.3M
That free cash flow number matters. APEI generated more cash in 2025 than it had in the previous three years combined. That’s not accounting noise — the business is actually producing money now.
The March 12 Double-Announcement
APEI dropped two press releases after the bell on March 12. The earnings release got all the attention, but the refinancing announcement is just as important for understanding the next 12 months.
The company replaced its existing debt with a new 5-year, $130M senior secured credit facility: a $90M term loan and a $40M revolver, maturing in March 2031. The borrowing spread dropped by 375 basis points. Expected annual interest savings: $3.7M. There’s a $1.6M one-time debt extinguishment loss hitting Q1 2026, but that’s the cost of improving the structure.
The other announcement: a new $50M share buyback authorization. At 18.1M diluted shares and a ~$1.06B market cap, $50M represents just under 5% of the float. If executed over 12-18 months, that mechanically lifts per-share earnings even before any revenue growth.
Analysts moved fast. B. Riley raised their target to $57, Lake Street to $56, Barrington to $56. All Strong Buy or Buy ratings. Seven analysts cover APEI and the consensus is “own it.”
Three Brands, One Story
APEI isn’t a single university — it operates three institutions serving roughly 109,000 students total.
APUS (American Public University System) is the core. It serves military, veteran, and government employees almost entirely online. APUS just launched MIT-powered coursework in machine learning, a new Master of Science in Computer Science, and a Bachelor of Science in Artificial Intelligence arriving summer 2026. Four new graduate concentrations (Quantum Computing, Robotics, Blockchain, Climate Resilience) went live in early 2026. This is the segment that gets hit by government shutdowns — but it also serves a population with the most stable, mission-driven enrollment incentives.
Rasmussen University is the healthcare play. Nursing shortage data from the Bureau of Labor Statistics projects 190,000+ RN job openings annually through 2033. Rasmussen opened its sixth Florida campus in Orlando in February 2026 — classes started April. New markets, real demand, no acquisition risk. This is organic growth.
Hondros College of Nursing is the smallest unit, focused on LPN and pre-licensure RN programs. It runs quietly and contributes to the nursing pipeline without attracting much analyst attention.
The Turnaround Arc
In 2021, APEI acquired Rasmussen University in a deal that looked sensible on paper. The execution was painful. Goodwill impairments hit in waves — fiscal 2022 produced a -$6.08 EPS loss, 2023 a -$2.93 loss. The stock fell from around $30 to under $5. For-profit education stocks were already politically toxic; APEI gave bears fresh ammunition.
The recovery starting in 2024 was methodical. Rasmussen’s cost structure got right-sized. APUS maintained enrollment while competitors fought for the same online learner demographic. Hondros kept growing. By 2024, APEI posted $0.55 in EPS — profitable for the first time in three years. FY2025 took that to $1.36.
The path to 2026 is clearer now. Analysts tracking APEI project revenue of $699.6M (+7.8%) and EPS in the $2.31–$3.04 range. At the $3.04 estimate and current price, you’re at a ~19x forward P/E. That’s not cheap for the sector — traditional for-profit education peers trade at low-to-mid teens — but APEI’s growth rate isn’t traditional.
If you want more context on how to spot small-cap turnaround signals early, our guide to watching SEC EDGAR 8-K filings covers exactly this type of debt refinancing catalyst.
Bull Case
The nursing shortage isn’t going away. Rasmussen’s healthcare enrollment is structural demand, not a cyclical trade. Every new campus APEI opens is revenue it didn’t have before.
APUS’s military and veteran base is as recession-proof as education gets. GI Bill benefits and military tuition assistance don’t contract in a downturn — if anything, military enrollment tends to rise when civilian job markets weaken. The new AI curriculum (MIT partnership, CS master’s, summer AI bachelor’s launch) gives APUS a legitimate differentiation angle in a crowded online education market.
Free cash flow went from $7.8M to $46.1M in one year. The new credit facility shaves $3.7M off annual interest costs. The $50M buyback shrinks the float. If the $3.04 EPS estimate plays out and shares outstanding drop even 3–4% from buybacks, actual EPS could run past $3.15.
Short interest is 9.85% with a 6.71 days-to-cover ratio. The 21% pop on March 13 likely squeezed some of those shorts — but at $57 with an RSI above 85, momentum traders are also getting uncomfortable. Shorts who covered are replaced by new ones betting on a mean reversion. That dynamic keeps pressure interesting in both directions. For comparisons on how breakout momentum plays can work in small caps, see our analysis of CITR’s wildfire protection breakout.
Bear Case
Every analyst who covers APEI has a target between $56 and $57. The stock is at $57.66. That’s not a huge problem — it means the analysts who know this company best think it’s priced about right — but it’s not a screaming margin of safety, either.
RSI hit 85.97 on March 13. At that reading, you’re in “things get extended and then don’t” territory. The stock has had one week to digest the earnings pop; how it holds the $52–$55 range in the next few weeks will tell you more about the next entry point than any model.
The DOGE and federal workforce angle is real and not well-covered. APUS’s government employee customer base is under pressure from federal headcount reductions. The Q4 shutdown impact was already disclosed. If the administration continues to reduce federal employment, APUS faces a structural enrollment headwind in its most stable segment. This isn’t speculation — it’s disclosed in the earnings call and visible in Q4 APUS revenue. How management guides Q1 2026 APUS enrollment will be the number to watch.
For-profit education regulatory risk is perpetual. Under any administration, the 90/10 rule, Gainful Employment regulations, and accreditation scrutiny can hit APEI’s operating model with little warning. It’s priced in at some level, but it never fully disappears. For-profit education has a long history of Washington deciding it doesn’t like the sector.
Q4 free cash flow was -$15.6M, making the full-year $46.1M FCF almost entirely a Q1–Q3 phenomenon. Watch whether that Q4 pattern continues into Q1 2026. If the new credit facility and cost structure improvements show up in Q1 FCF, that’s confirmation. If not, it’s a question mark on the full-year number.
You can see similar earnings-pop dynamics at work in our CleanSpark analysis — a small cap where the gap between reported metrics and sentiment created both opportunity and risk depending on your entry point.
Key Metrics at a Glance
- Price: $57.66 (as of March 13, 2026 close)
- Market cap: ~$1.06B
- 52-week range: $20.75–$57.66
- P/E (TTM): 42.6x | Forward P/E: ~19x
- FY2025 EPS: $1.36 | FY2026E EPS: $2.31–$3.04
- FY2025 Revenue: $648.9M | FY2026E Revenue: ~$699M
- Adjusted EBITDA: $85.7M (+18.6%)
- FCF: $46.1M (vs $7.8M in FY2024)
- Short float: 9.85% | Short ratio: 6.71 days
- Buyback: $50M authorized
- Analyst consensus: Strong Buy | Avg target: $56–57
Verdict
The turnaround is real. APEI went from burning $6 per share in 2022 to generating $1.36 in earnings and $46M in free cash flow in 2025. That recovery required a debt structure overhaul, a Rasmussen write-down that’s now in the rearview, and management that kept its head down and executed while the stock was at $5. The fundamentals today are the best they’ve been since before the Rasmussen deal.
The problem is that anyone who bought APEI in the last 12 months already made 173%. You didn’t. The 21% pop on March 13 priced in the good news, and the stock is now sitting above every analyst target within 24 hours of those targets being raised.
Compelling at $48–52. Fully priced at $57. The numbers for 2026 need to keep coming in — and specifically, Q1 2026 needs to show that the APUS federal enrollment headwind isn’t accelerating. If it does, and the stock pulls back to the $50 range, the forward P/E at $3 EPS drops to ~17x with a buyback running and a refinanced balance sheet. That’s a real position. Today at $57.66, you’re paying for optimism that’s already visible to everyone.
Watch the Q1 2026 earnings call. If APUS enrollment holds despite federal headcount pressures, buy the next dip. If it misses, you’ll get a better entry.
This is not financial advice. Do your own research before making any investment decisions. The author holds no position in APEI.